Skip to main content
Clinical Trials/NCT03258944
NCT03258944
Completed
Not Applicable

Breath-Stacking and Ventilatory Muscle Strength

Federal University of Health Science of Porto Alegre1 site in 1 country34 target enrollmentSeptember 1, 2017
ConditionsMuscle Weakness

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Muscle Weakness
Sponsor
Federal University of Health Science of Porto Alegre
Enrollment
34
Locations
1
Primary Endpoint
Ventilatory Muscle Strength
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

In several diseases in which muscle weakness is a determining factor for morbidity and mortality, inspiratory muscle training has been shown to be useful in improving the function of ventilatory muscles, delaying or minimizing the development of complications due to the reduction of inspiratory muscle strength.

The breath-stacking technique emerges as an easily applicable alternative, and it can be used in poorly collaborative patients. The technique described in the literature aims to increase pulmonary volumes.

This gain occurs with the coupling of a silicone mask on the patient's face, a unidirectional valve and with the expiratory branch occluded. Thus, inspirations occur sequentially in this medium, generating pulmonary hyperinflation and increasing the contractility power of the expiratory muscles, which are fundamental for coughing. This hyperinflation also improves the peripheral air distribution in the lungs by increasing intrathoracic pressure.

The objective of this study is to evaluate the effect of the breath-stacking (BS) technique on the ventilatory muscle strength of young and healthy individuals.

Detailed Description

Initially, participants will be submitted to a learning session on the evaluation of ventilatory muscle strength and the breath-stacking technique. Between 24-72 hours after the learning, the evaluation of the muscular muscular strength will be performed through the maximal inspiratory pressure (MIP) and the maximum expiratory pressure (MEP). PI max will be measured from a maximum expiration; While PE max will be measured from a maximum inspiration, using a digital manovacuometer (MVD 300®)

Registry
clinicaltrials.gov
Start Date
September 1, 2017
End Date
December 1, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Federal University of Health Science of Porto Alegre
Responsible Party
Principal Investigator
Principal Investigator

Fabrício Edler Macagnan

PhD

Federal University of Health Science of Porto Alegre

Eligibility Criteria

Inclusion Criteria

  • No signs and symptoms of pulmonary diseases, normal ventilatory muscle strength and agreement to participate and sign the informed consent form.

Exclusion Criteria

  • Presenting neuromuscular diseases, claustrophobia, ruptured eardrum, history of spontaneous pneumothorax and playing wind instruments or being a singer. Sample loss will be considered as non-attendance at all training sessions.

Outcomes

Primary Outcomes

Ventilatory Muscle Strength

Time Frame: four weeks

Maximum inspiratory and expiratory pressure

Study Sites (1)

Loading locations...

Similar Trials